fluorescein-5-isothiocyanate has been researched along with Glaucoma, Suspect in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, J; Li, X; Liu, Z; Meng, J; Ye, L; Zhang, Z; Zhao, Z | 1 |
Drecoll, E; Guerra, T; Kharlamb, A; Krauss, AH; Lütjen-Drecoll, E; Nieves, A; Nilsson, SF; Toris, CB; Woodward, DF | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Glaucoma, Suspect
Article | Year |
---|---|
Acute ocular hypertension disrupts barrier integrity and pump function in rat corneal endothelial cells.
Topics: Actins; Animals; Cell Count; Cells, Cultured; Dextrans; Disease Models, Animal; Endothelial Cells; Endothelium, Corneal; Fluorescein-5-isothiocyanate; Ocular Hypertension; Permeability; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Zonula Occludens-1 Protein | 2017 |
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
Topics: Administration, Topical; Alprostadil; Animals; Aqueous Humor; Ciliary Body; Dextrans; Disease Models, Animal; Fluorescein-5-isothiocyanate; Fluorophotometry; Intraocular Pressure; Macaca fascicularis; Muscle, Smooth; Ocular Hypertension; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Sclera; Trabecular Meshwork; Uvea | 2006 |